GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

FluoroPharma Medical FPMI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2016

Net income

−$2.0m

FY2014FY2016

Free cash flow

−$881,414

FY2014FY2016

Shareholders' equity

−$10.2m

FY2014FY2016

Income statement

Fiscal years

FY2016FY2015FY2014
Gross profit−$43,912−$46,366—
Research and development$511,381$720,861$1,754
Operating income−$2.2m−$3.2m−$5,169
Net income−$2.0m−$3.2m−$4,692
Diluted earnings per share-0.06-0.10-0.00

Balance sheet

At each fiscal year end

FY2016FY2015FY2014
Total assets$334,760$974,858$820,191
Cash and short-term investments$24,723$290,847$292,075
Total liabilities$10.5m$8.8m$5.6m
Debt$5.8m$4.5m$2.1m
Shareholders' equity−$10.2m−$7.9m−$4.8m
Shares outstanding34m32m29m

Cash flow

Fiscal years

FY2016FY2015FY2014
Cash from operations−$880,121−$2.7m−$3.3m
Capital spending−$1,293−$6,694−$356,564
Free cash flow−$881,414−$2.7m−$3.7m

Latest quarters

By quarter end

Dec 2016Sept 2016Jun 2016Mar 2016Dec 2015Sept 2015Jun 2015Mar 2015
Operating income−$521,470−$319,621−$679,367−$681,971−$835,519−$784,592−$705,187−$861,041
Net income−$127,234$384,107−$734,100−$1.6m−$1.3m$104,908−$1.4m−$574,096
Diluted earnings per share-0.000.01-0.02-0.05-0.040.00-0.05-0.02
Total assets$334,760$387,266$772,584$456,858$974,858$2.0m$519,017$558,730
Cash and short-term investments$24,723$27,502$408,309$41,172$290,847$1.3m$42,042$85,964
Debt$2.7m$2.8m$2.7m$5.0m$4.5m$4.3m$2.7m$2.3m
Shareholders' equity−$10.2m−$9.9m−$10.2m−$9.5m−$7.9m−$6.9m−$6.9m−$5.4m

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return100%100%167%15117%174%11211%108%55%-54%-57%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.